Core Viewpoint - China National Chemical Corporation's subsidiary Tianchen Qixiang New Materials Co., Ltd. has successfully completed a 72-hour full-load performance assessment for its nylon new materials project, achieving or exceeding design values in key technical and economic indicators, indicating stable and controllable product quality and efficient system operation [1] Group 1 - The nylon new materials project has reached full production capacity and has transitioned into a phase of efficient and stable operation [1] - The successful implementation of the project is expected to enhance production efficiency, reduce production costs, and increase market supply capacity [1] - The project will positively impact the company's industry influence and market competitiveness, contributing to its future development [1]

Core Viewpoint - China Chemical's subsidiary, Ningbo Engineering Co., has received a lawsuit notification regarding securities fraud claims against Kangde Xin Composite Materials Group Co., with a total claim amount of approximately RMB 4.139 billion [1][2]. Group 1: Lawsuit Details - The lawsuit involves 40 defendants, including Kangde Xin, Yulong Automotive Group, Ruihua Certified Public Accountants, and Hengtai Changcai Securities [1]. - The plaintiffs, led by Hu Juling, are seeking compensation for investment losses due to false statements, including damages, stamp duty, and commissions [1]. - The plaintiffs also request that all defendants cover additional costs, estimated at RMB 3 million, related to the lawsuit [1]. Group 2: Company Position - China Chemical has preliminarily verified that Ningbo Engineering did not knowingly assist Kangde Xin in financial fraud and is not the main responsible party in this case [2]. - The company assesses that this lawsuit will not have a significant impact on its current or future profits [2]. Group 3: Company Background and Performance - Ningbo Engineering, a wholly-owned subsidiary of China Chemical, was established in 2002 and specializes in various engineering services across multiple sectors [2]. - For the first three quarters, China Chemical reported revenue of RMB 136.3 billion, a year-on-year increase of 1.15%, and a net profit of RMB 4.232 billion, up 10.28% year-on-year [4].

Group 1 - Heng Rui Pharmaceutical has 9 drugs included in the national medical insurance directory for the first time, with an estimated total sales of approximately 8.66 billion yuan for 2024 and 7.55 billion yuan for the first three quarters of 2025 [5] - Junshi Biosciences' products Tuoyi® and Junshida® have been added to the national medical insurance directory, enhancing patient affordability and market promotion [6] - Huadong Medicine's subsidiary has products included in the national medical insurance and commercial insurance innovative drug directories, expected to aid in market promotion [7] Group 2 - Aidi Pharmaceutical's two innovative HIV drugs have successfully renewed their inclusion in the national medical insurance directory, with specific reimbursement prices set [8] - Fuxing Pharmaceutical has multiple products newly included in the national medical insurance directory, which is anticipated to positively impact future performance [9] - Weichuang Biotechnology's product has been included in the national medical insurance directory, which is expected to enhance market promotion and sales [10] Group 3 - Muxi Co., Ltd. announced a final online issuance rate of 0.03348913% after the mechanism was activated, with a total of 22.83 million shares issued [2] - Doushan New Materials reached a consensus on production reduction in the BOPET industry, although the sustainability of long-term price increases remains uncertain [2] - Guanglian Aviation's controlling shareholder has had the detention lifted, allowing normal operations to resume [3] Group 4 - Jiangjian Co., Ltd. clarified that it bears no obligations for any overdue financial products related to its controlling shareholder, confirming normal operations [4] - Tian Ci Materials' controlling shareholder has committed not to reduce holdings, holding 34.35% of the shares [13] - Annie Co., Ltd. is planning a change in control, with stock resuming trading on December 8 [14]

Group 1 - The core point of the article is that China Chemical (SH 601117) held its 32nd meeting of the fifth board of directors on December 5, 2025, via telecommunication, where it reviewed the proposal for appointing an assistant general manager [1] - For the first half of 2025, China Chemical's revenue composition was as follows: Chemical Engineering accounted for 82.46%, Infrastructure 10.04%, Other Industries 5.32%, Modern Services 0.89%, and Other Businesses 0.72% [1] - As of the time of reporting, China Chemical's market capitalization was 46.8 billion yuan [1]

Core Viewpoint - China Chemical's subsidiary, Saiding Ningbo, is involved in a lawsuit regarding false securities statements against Kangde Xin Composite Materials Group, with a claim for compensation amounting to approximately 4.139 billion yuan [1][2]. Group 1: Lawsuit Details - The lawsuit was initiated by investors, including Hu Juling, seeking damages for investment losses due to alleged false statements made by Kangde Xin [1]. - The total compensation requested includes investment loss, stamp duty, and commission, amounting to 4.139 billion yuan, along with additional costs estimated at 3 million yuan for various fees [1]. - Saiding Ningbo is one of over forty defendants in the case and is not considered the primary responsible party [2]. Group 2: Company Position - As of the announcement date, the lawsuit has not yet gone to trial, and no legally binding judgments or rulings have been made [2]. - Preliminary assessments indicate that Saiding Ningbo did not knowingly assist Kangde Xin in any financial fraud [2]. - The company believes that the lawsuit will not have a significant impact on its current or future profits [2].

证券代码：601117 股票简称：中国化学 公告编号：临 2025-062 中国化学工程股份有限公司 关于孙公司收到应诉通知书的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误 导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法 律责任。 重要内容提示： 中国化学工程股份有限公司（以下简称"公司"）孙公司中国 化学赛鼎宁波工程有限公司（以下简称"赛鼎宁波"）近日收到江 苏省苏州市中级人民法院送达的《应诉通知书》，获悉赛鼎宁波涉 及胡菊玲等投资者以证券虚假陈述责任纠纷对康得新复合材料集团 股份有限公司提起的诉讼。截至本公告日，该诉讼事项尚未开庭审 理。 一、本案基本信息 （一）诉讼各方当事人 原告：胡菊玲等人 1 案件所处的诉讼阶段：法院已立案受理，尚未开庭审理。 公司下属孙公司当事人地位：共同被告（被告三十一）。 诉讼代表人：陈群星、巫春霞、魏伟、王玲玲、魏波 4.请求法院判令本案诉讼费用全部由被告承担。 三、对公司本期利润或期后利润的影响 2 被告一：康得新复合材料集团股份有限公司 被告二：康得投资集团有限公司 被告三：张家港康得新光电材料有限公司 被告四：张家港保税区康得菲尔实 ...

该项目正式达产后，将进一步提升生产效率、降低生产成本， 增加市场的供货能力，提升公司行业影响力和市场竞争力，对公 司未来发展产生积极影响。 受国家相关行业政策、经济运行周期及市场供求变化等因素 影响，该项目可能面临产品销售价格及原材料价格波动、竞争加 剧等不利因素的影响。敬请投资者注意投资风险。 1 证券代码：601117 股票简称：中国化学 公告编号：临 2025-061 中国化学工程股份有限公司 关于尼龙新材料项目达产的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 由中国化学工程股份有限公司（以下简称"公司"）三级控 股子公司天辰齐翔新材料有限公司实施的公司非公开发行募投 项目尼龙新材料项目（以下简称"项目"或"该项目"），在日 前进行的 72 小时满负荷性能考核中，己二腈装置各项关键技术、 经济指标均达到或优于设计值，产品质量稳定可控，系统运行平 稳高效，目前已全面达产并转入高效稳定的运行阶段。 中国化学工程股份有限公司 二〇二五年十二月八日 2 ...

证券代码：601117 股票简称：中国化学 公告编号：临 2025-060 重要内容提示： 一、董事会会议召开情况 中国化学工程股份有限公司第五届董事会第三十二次会议 通知于 2025 年 11 月 28 日发出，会议于 2025 年 12 月 5 日以通 讯方式召开。本次会议应出席董事 7 人，实际出席董事 7 人。会 议由董事长莫鼎革先生主持。本次会议的召开符合有关法律法规、 规范性文件和《公司章程》《董事会议事规则》的相关规定。 二、董事会会议审议情况 《关于聘任公司总经理助理的议案》 同意聘任胡永红先生为公司总经理助理，任期与本届董事会 任期相同。免去其总经济师职务。 中国化学工程股份有限公司 第五届董事会第三十二次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 表决结果：通过。同意 7 票，反对 0 票，弃权 0 票。 中国化学工程股份有限公司 二〇二五年十二月八日 2 附件： 胡永红先生简历 1 公司全体董事均出席本次董事会。 本次董事会所有议案均获通过。 胡永红先生，1970 年 10 月出生，大 ...

Core Viewpoint - China Chemical announced that its subsidiary, Saiding Ningbo, has received a "Notice of Response" regarding a lawsuit filed by investors, including Hu Juling, against Kangde Xin for securities false statement liability. The plaintiffs are seeking compensation of 4.139 billion yuan for investment losses, with additional claims for announcement fees of 3 million yuan and litigation costs [1] Summary by Relevant Sections - **Lawsuit Details** - The lawsuit involves claims against Kangde Xin for a total of 4.139 billion yuan in compensation for investment losses [1] - The plaintiffs also request that other defendants bear joint liability and cover additional costs of 3 million yuan for announcement fees and litigation expenses [1] - **Company's Position** - As of the announcement date, the lawsuit has not yet gone to court [1] - Preliminary verification indicates that Saiding Ningbo was not involved in any financial fraud and is not a primary responsible party [1] - The expected impact on the company's profits is deemed negligible [1]

中国化学公告，公司孙公司中国化学赛鼎宁波工程有限公司作为共同被告，涉及胡菊玲等投资者以证券 虚假陈述责任纠纷对康得新复合材料集团股份有限公司提起的诉讼。原告请求判令被告一康得新复合材 料集团股份有限公司支付投资损失约41.39亿元，并要求其他被告承担连带赔偿责任。公司初步评估， 本案不会对本期利润或期后利润产生实质影响。 ...